[Federal Register Volume 66, Number 205 (Tuesday, October 23, 2001)]
[Notices]
[Page 53647]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-26660]



[[Page 53647]]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration on the Boston Stock Exchange, Inc. (DrugMax, Inc., 
Common Shares, $.001 Par Value) File No. 1-15445

October 17, 2001.
    DrugMax, Inc., a Nevada corporation (``Issuer''), has filed an 
application with the Securities and Exchange Commission 
(``Commission''), pursuant to Section 12(d) of the Securities Exchange 
Act of 1934 \1\ (``Act'') and Rule 12d2-2(d) thereunder,\2\ to withdraw 
its Common Shares, $.001 par value (``Security'') from listing and 
registration on the Boston Stock Exchange, Inc. (``BSE'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Issuer stated in its application that the Security has been 
listed on the Nasdaq SmallCap Market since November 19, 1999. In making 
the decision to withdraw the Security from listing and registration on 
the BSE, the Issuer considered the liquidity provided by the BSE and 
the cost associated with maintaining such listing. The Issuer 
represented that it will maintain its listing on the Nasdaq SmallCap 
Market so that the shareholders are provided with accessible and liquid 
markets. The Issuer's application relates solely to the Security's 
withdrawal from listing on the BSE and from registration under Section 
12(b) of the Act \3\ and shall not affect its obligation to be 
registered under Section 12(g) of the Act.\4\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(b).
    \4\ 15 U.S.C. 78l(g).
---------------------------------------------------------------------------

    Any interested person may, on or before November 8, 2001 submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon 
whether the application has been made in accordance with the rules of 
the BSE and what terms, if any, should be imposed by the Commission for 
the protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.
---------------------------------------------------------------------------

    \5\ 17 CFR 200.30-3(a)(1).

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\3\
Jonathan G. Katz,
Secretary.
[FR Doc. 01-26660 Filed 10-22-01; 8:45 am]
BILLING CODE 8010-01-M